Identification, Molecular Docking Mechanism and Cellular Activity of Selenium-Enriched ACE Inhibitory Peptides from Oysters
Molecules · 2025
DOI: 10.3390/molecules30244818 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Zhuangzhuang Yue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Green Chemical Materials and Safety Technology, School of Petroleum and Chemical Engineering, Beibu Gulf University, Qinzho…. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Angiotensin-Converting Enzyme Inhibitors, Selenium, Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Guangxi Key Research and Development Plan, the counterpart aid project for discipline construction from Guangxi University.
Abstract (Originalsprache)
Selenium-enriched oyster proteins were hydrolyzed using trypsin to obtain peptides with angiotensin-I-converting enzyme (ACE) inhibitory activity. The hydrolysate was purified by ultrafiltration and two-step reversed-phase high-performance liquid chromatography (RP-HPLC), yielding the most active fraction M4-2 (selenium content: 37.00 ± 0.56 mg/kg; IC50: 0.774 mg/mL, significantly lower than the IC50 of the crude hydrolysate, 2.801 mg/mL). This fraction was further analyzed by LC-MS/MS and molecular docking, leading to the identification of 91 selenium-containing peptide sequences. Two novel peptides, SeMFRTSSK and QASeMNEATGGK, showing strong binding affinities (−9.8 and −9.0 kcal/mol, respectively), were selected. Molecular docking revealed that SeMFRTSSK bound to key residues in the ACE active pocket via hydrogen bonds, whereas QASeMNEATGGK interacted with the Zn2+ active center. Cellular assays using EA.hy926 cells demonstrated that both peptides were non-cytotoxic at concentrations up to 0.25 mg/mL. At 0.025 mg/mL, SeMFRTSSK and QASeMNEATGGK enhanced cellular NO release by 202.65% and 273.45%, respectively, while suppressing Endothelin-1 (ET-1) secretion by 18.03% and 27.86%, compared to the blank control group. Notably, these peptides induced higher levels of NO release and greater suppression of ET-1 secretion than those in the captopril-treated positive control group. These findings support selenium-enriched oyster-derived peptides as potential natural antihypertensive ingredients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Green Chemical Materials and Safety Technology, School of Petroleum and Chemical Engineering, Beibu Gulf University, Qinzhou 535011, China.
- Guangdong Provincial Key Laboratory of Nutraceuticals and Functional Foods, College of Food Science, South China Agricultural University, Guangzhou 510642, China.
Förderung
- the Guangxi Key Research and Development Plan
- the counterpart aid project for discipline construction from Guangxi University
Zitieren
APA
Yue, Z., Xia, Z., Xu, F., Chen, B., Jiao, S., Liang, X., Yin, Y., & Miao, J. (2025). Identification, Molecular Docking Mechanism and Cellular Activity of Selenium-Enriched ACE Inhibitory Peptides from Oysters. Molecules. https://doi.org/10.3390/molecules30244818
Vancouver
Yue Z, Xia Z, Xu F, Chen B, Jiao S, Liang X, et al. Identification, Molecular Docking Mechanism and Cellular Activity of Selenium-Enriched ACE Inhibitory Peptides from Oysters. Molecules. 2025. doi:10.3390/molecules30244818
BibTeX
@article{Yue2025,
author = {Yue, Zhuangzhuang and Xia, Zhen and Xu, Fei and Chen, Bingbing and Jiao, Shufei and Liang, Xingtang and Yin, Yanzhen and Miao, Jianyin},
title = {Identification, Molecular Docking Mechanism and Cellular Activity of Selenium-Enriched ACE Inhibitory Peptides from Oysters},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30244818}
}
EUVIMED